Does the HCG trigger dose used for IVF impact luteal progesterone concentrations? a randomized controlled trial
MedicinaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Reproductive biomedicine online
- Publicado em
- 6 mai 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Does the HCG trigger dose used for IVF impact luteal progesterone concentrations? a randomized controlled trial
Louise Svenstrup, Sören Möller, Jens Fedder, Dorrit Elschner Pedersen, Karin Erb, Claus Yding Andersen, Peter Humaidan
Descritores MeSH
- Chorionic Gonadotropin
- Progesterone
- Fertilization in Vitro
- Hormone Antagonists
- 17 alpha-Hydroxyprogesterone Caproate
- Gonadotropin-Releasing Hormone
- Lipopolysaccharides
- Luteal Phase
- Ovulation Induction
- Humans
Estudos relacionados
- Investigation of luteal HCG supplementation in GnRH-agonist-triggered fresh embryo transfer cycles: a randomized controlled trial
- Comparison of pregnancy rates in antagonist cycles after luteal support with GnRH-agonist versus progesterone: prospective randomized study
- Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium
- Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis